Navigation Links
Shareholder Class Action Filed Against Elan Corporation, plc by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
Date:12/11/2008

RADNOR, Pa., Dec. 11 /PRNewswire/ --The following statement was issued today by the law firm of Barroway Topaz Kessler Meltzer & Check, LLP:

Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Southern District of New York on behalf of purchasers of the securities of Elan Corporation, plc (NYSE: ELN) ("Elan" or the "Company") between May 21, 2007 and October 21, 2008, inclusive (the "Class Period").

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Barroway Topaz Kessler Meltzer & Check, LLP (Darren J. Check, Esq. or David M. Promisloff, Esq.) toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at info@btkmc.com.

The Complaint charges Elan and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Elan is a neuroscience-based biotechnology company. The Complaint alleges that during the Class Period the Company made materially false and misleading statements about bapineuzumab, a drug Elan was developing in association with Wyeth for the treatment of Alzheimer's disease. Specifically, Defendants failed to disclose unfavorable results from a Phase II clinical study of bapineuzumab that Elan and Wyeth conducted. When those results were disclosed on July 29, 2008, the price of Elan's shares plunged from $33.75 to $19.63 on extremely high volume. On October 22, 2008, it was reported that some European regulators had asked that trials of bapineuzumab be delayed following the mixed results of the mid-stage U.S. trials. On this news, the price of Elan's shares fell from $9.06 per share to $7.82 per share.

Plaintiff seeks to recover damages on behalf of class members and is represented by the law firm of Barroway Topaz Kessler Meltzer & Check which prosecutes class actions in both state and federal courts throughout the country. Barroway Topaz Kessler Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.

For more information about Barroway Topaz Kessler Meltzer & Check or to sign up to participate in this action online, please visit www.btkmc.com.

If you are a member of the class described above, you may, not later than December 15, 2008, move the Court to serve as lead plaintiff of the class, if you so choose. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the purported class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

    CONTACT:      Barroway Topaz Kessler Meltzer & Check, LLP
                  Darren J. Check, Esq.
                  David M. Promisloff, Esq.
                  280 King of Prussia Road
                  Radnor, PA 19087
                  1-888-299-7706 (toll free) or 1-610-667-7706
                  Or by e-mail at info@btkmc.com


'/>"/>
SOURCE Barroway Topaz Kessler Meltzer & Check, LLP
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
2. Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger
3. Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
4. Trinity Biotech Investor Group Initiates Campaign of ADR Conversion to Force a Special Meeting of Shareholders
5. Trinity Biotech Management Refuses to Honor Call for a Special Meeting of Shareholders
6. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
7. Human Pheromone Sciences, Inc. - Shareholder Update
8. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
9. ProtoKinetix Partners with OTC Financial Network to Increase Shareholder Base
10. Insmed to Seek Shareholder Approval for Reverse Split
11. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Northwell Health ... the advance of precision cancer research. ... largest health care provider, Northwell Health diagnoses ... Indivumed, GmbH is a Germany ... medical therapies. Together they will greatly expand cancer ...
(Date:1/17/2017)... Belgium (PRWEB) , ... January 17, 2017 , ... ... sample preparation and epigenetics research, recently announced a collaboration with the Heidelberg University ... DNA amplification method for library preparation, following the company’s successful launch of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... the prestigious Tibbetts Award from the U.S. Small Business Administration. The ... created a significant economic or social impact […] and are considered the best of ...
(Date:1/13/2017)... 13, 2017 Research and Markets has announced the ... offering. ... market to grow at a CAGR of 16.83% during the period 2017-2021. ... prospects of the global biopolymers market for 2017-2021. To calculate the market ... of biopolymer products. The report also includes a a discussion of the ...
Breaking Biology Technology:
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
(Date:12/15/2016)... ... and Markets has announced the addition of the "Global Military Biometrics ... forecasts the global military biometrics market to grow at a CAGR of ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/15/2016)... 14, 2016 "Increase in mobile transactions is ... mobile biometrics market is expected to grow from USD ... 2022, at a CAGR of 29.3% between 2016 and ... the growing demand for smart devices, government initiatives, and ... "Software component is expected to grow at a high ...
Breaking Biology News(10 mins):